The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients (pts) with advanced non-small-cell lung cancer (NSCLC): Survival and clinical activity by subgroup analysis.
Julie R. Brahmer
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Research Funding - Bristol-Myers Squibb
Leora Horn
Consultant or Advisory Role - Bristol-Myers Squibb
Leena Gandhi
No relevant relationships to disclose
David R. Spigel
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Scott Joseph Antonia
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Research Funding - MedImmune
Naiyer A. Rizvi
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb; MedImmune; Roche/Genentech
John D. Powderly
Employment or Leadership Position - Biologics Human Application Lab
Consultant or Advisory Role - Amplimmune; Bristol-Myers Squibb; Genentech; Merck
Honoraria - Bristol-Myers Squibb
Research Funding - Amplimmune; Bristol-Myers Squibb; Genentech; Merck
Other Remuneration - Bristol-Myers Squibb
Rebecca Suk Heist
Research Funding - Genentech; GlaxoSmithKline; Novartis; Pfizer
Richard D. Carvajal
No relevant relationships to disclose
David Michael Jackman
Consultant or Advisory Role - Cowan Group; Foundation Medicine; Genentech
Honoraria - Roche
Lecia V. Sequist
Consultant or Advisory Role - AstraZeneca (U); Boehringer Ingelheim (U); Clovis (U); Merrimack Pharmaceuticals (U)
David C. Smith
Research Funding - Bristol-Myers Squibb
Philip D. Leming
No relevant relationships to disclose
Suzanne Louise Topalian
Consultant or Advisory Role - Bristol-Myers Squibb (U); Jounce Therapeutics; Sanofi
Research Funding - Bristol-Myers Squibb
Other Remuneration - Amplimmune (I); Bristol-Myers Squibb (I)
F. Stephen Hodi
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Mario Sznol
Consultant or Advisory Role - Amgen; Anaeropharma; Bristol-Myers Squibb; Genentech; MedImmune; Nektar; Symphogen
Christopher Harbison
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Georgia Kollia
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Ashok Kumar Gupta
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Scott N. Gettinger
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb